Just Live an athlete owned performance CBD brand has partnered with wellness company, Vertical Wellness and canafarma to release a line of sparkling water.
A professional skateboarder and multiple X Games gold medalist Paul Rodriguez co-founded the brand with professional soccer player and World Cup winner, Alex Morgan. They were joined by NBA Championship winner Klay Thompson and motocross competitor Travis Pastrana.
The CBD infused sparkling waters will include flavours such as meyer lemon, cranberry raspberry, lime with mint, clementine, mixed berry and grapefruit. Each drink will contain 25 mg of CBD and are THC and alcohol-free. The launch in late 2021 will focus on six different U.S. markets, with national expansion estimated for 2022.
Smoke Wallin, the CEO of Vertical Wellness said: “There’s no brand out there with this kind of athletic support. I couldn’t be more excited to be introducing Just Live CBD Sparkling Waters with our national distributors to our major retailers and hospitality partners in select markets.”
Professional skateboarder injury recovery
All of the athletes involved in Just Live have their own CBD experience. Motocross, soccer, basketball and skateboarding can cause a range of injuries especially as an athlete’s career progresses.
Skateboarding in particular can cause high impact blows to the body. While it can cause cuts or scrapes, the most common skateboarding injuries are fractures, especially the wrists. Paul Rodriguez has won countless major professional skateboarding events such as the 2014 X-Games where he took gold in the street event. His first major injury occurred while skating a stair set where his right leg went the opposite way from his body leaving him with a torn anterior cruciate ligament (ACL), torn right and left meniscus and a tear in his MCL.
Following surgery, he chose to replace opioids with CBD before incorporating it into his daily routine as well as professional skateboarding training.
Co-founder Alex Morgan is known for being one of the youngest members of the U.S Women’s National Soccer Team. She won a Gold Olympic Medal against Japan in the Summer Games in 2012 and co-captained the U.S team to victory in the FIFA World Cup 2019.
In a statement on the Just Live site, she says she uses CBD to unwind and also to help with shoulder pain. “I have a convincing experience when I sprained my shoulder and had a match 3 days later. I’ve used CBD on muscle aches and pains ever since. I also have a hard time winding down after a game, and have found that I am able to go to sleep earlier after a game and feel more rested when I have a CBD capsule or tincture following the match.”
Rapper Lil’ Kim announces new cannabis brand ‘aphrodisiac’
The New York rapper becomes the latest celebrity to launch their own cannabis collection which is due in 2022.
The singer has announced the launch of her own cannabis brand, Aphrodisiac which is being produced in partnership with Superbad inc.
Lil Kim’s new products will be available across California in 2022, although there is no official launch date announced.
The brand is being produced in collaboration with the innovative cannabis brand, Superbad inc. Superbad was established in 2020 combining cutting edge technology and sleek design for cannabis consumers. They currently have seven acres of indoor grow and a “state-of-the-art facility” employing over 200 people.
Kimberly Denise Jones who goes by her stage name, Lil’ Kim has been working on the brand for two years. She has also partnered with the brand CampNova, which offer vertically integrated marketing and a distribution platform.
The rapper wants the cannabis line to reflect her personal style and says she has personally tested her own products. The collection is tailored to Lil’ Kim’s own preference in genetics and strains.
Lil’ Kim collection
There are plans to expand the range to other legal states such as Michigan, New Jersey and New York. Originally from New York, Lil’ Kim hopes to be able to release the collection in her home state.
In an interview with Forbes magazine, she said: “I’ve actually been working on this for about two and a half to three years. This is something that didn’t just come overnight. It’s something I’ve always wanted to do.”
Lil’ Kim is the latest celebrity to enter the cannabis space with her own collection. Earlier this year, Justin Bieber announced he would be releasing a collection of pre-rolls called Peaches with premium brand Palms. The products are currently available in California, Nevada, Massachusetts and Florida.
In a press release, he stated: “I’m a fan of Palms and what they are doing by making cannabis approachable and helping to destigmatise it — especially for the many people who find it helpful for their mental health.”
Always Pure Organics: A day in the life with Chikako Yoshida
Regional Director of Asia, Chikako Yoshida, gives us a glimpse of her typical workday and discusses working in cannabis.
Chikako Yoshida, regional director of Asia for Always Pure Organics shares her experience of working in the cannabis industry.
Always Pure Organics is excited to give you a glimpse behind the curtain once again.
Join us for our latest episode of a Day in the Life, in which regional director of Asia, Chikako Yoshida discusses her experience working for Always Pure Organics and in the cannabis industry.
In this episode, we follow our Regional Director of Asia, Chikako Yoshida, as she takes us through her typical workday. Having previously worked in counterterrorism for the United Nations, Chikako joined the APO team in May 2020. Chikako has such an interesting story to tell, we’re honoured to have her on the team as she embodies our mission to cultivate cannabis acceptance and accessibility worldwide.
Chikako Yoshida said: “Upon learning about the power of cannabis and seeing the high potential growth of Always Pure Organics, I decided to change career from preventing illicit drugs to promoting cannabis to help people in need. I feel that by joining APO, I can help fulfil my life’s mission to support children and their families who fight against illness and sickness by providing them with cannabis products.”
CBGA may be ‘more potent’ than CBD against seizures in Dravet syndrome
Dr Lyndsey Anderson said there is more to explore when it comes to creating more treatment options for Dravet syndrome.
Scientists say they have found the ‘Mother of all cannabinoids’ which may help to reduce seizures in Dravet syndrome.
A new study on mice from the University of Sydney found that three acidic cannabinoids found in cannabis reduced seizures in Dravet syndrome, an intractable form of childhood epilepsy.
The three cannabinoids are cannabigerolic acid (CBGA), cannabidivarinic acid (CBDVA), cannabigerovarinic acid (CBGVA). All three but CBGA in particular “may contribute to the effects of cannabis-based products in childhood epilepsy” noted the researchers and were found to potentially have ‘anticonvulsant properties.”
The study marks the first time that three acidic cannabinoids were found to potentially help reduce seizures for Dravet syndrome.
Speaking with Cannabis Health News, the lead author of the study, Dr Lyndsey Anderson, said: “We found that CBGA exhibited both anticonvulsant and pro-convulsant effects. CBGA was more potent than CBD against febrile seizures in a mouse model of Dravet syndrome. We also found that a combination of CBGA and clobazam was more effective than either treatment alone. Additionally, we found that CBGA was anticonvulsant in the maximal electroshock acute seizure model, a model for generalized tonic-clonic seizures.”
She added: “CBGA did, however, present some proconvulsant effects. The frequency of spontaneous seizures in the mouse model of Dravet syndrome was increased with a high dose of CBGA. Also, CBGA was proconvulsant in the 6-Hz acute seizure model, a model of focal, psychomotor seizures.”
Although CBGA shows promise, Dr Anderson also stressed that it needs more research before it can replace CBD. She cautioned that Dravet syndrome patients may still need to proceed with caution.
“Artisanal cannabis-based products are believed to reduce seizures in Dravet syndrome patients,” she said. “As these oils contain rare cannabinoids like CBGA, it is possible CBGA then contributes to the anticonvulsant effects of these artisanal cannabis oils. However, there were proconvulsant effects observed with CBGA, suggesting that Dravet syndrome patients may need to proceed with caution. The proconvulsant liability of CBGA would need to be addressed before it replaced CBD as an anticonvulsant.”
What is CBGA?
Sometimes referred to as ‘the mother of all cannabinoids,’ CBGA is the precursor molecule to many different cannabinioids including CBD and THC. It is thought to help some diseases such as colon cancer, metabolic disease and cardiovascular disease. It is a non-intoxicating cannabinoid much like CBD.
Dr Anderson explains that more research is needed to explain how the three cannabinoids work together.
“We don’t know how they work together yet,” she said. “We found that CBGA, CBDVA and CBGVA were all individually anticonvulsant against thermally induced seizures in the mouse model of Dravet syndrome. We did not investigate whether a combination of these three cannabinoids would result in a greater anticonvulsant effect than either cannabinoid alone. Future work will definitely explore this possibility.”
CBGA future research
This isn’t the end of the research into CBGA for Dravet Syndrome. Dr Anderson said there is more to explore when it comes to creating more treatment options for Dravet syndrome.
She said: “Next on the horizon for this research is to explore whether the anticonvulsant properties of CBDVA and CBGVA translate to other seizure types including spontaneous seizures in the mouse model of Dravet syndrome. Additionally, we have extensively interrogated the anticonvulsant potential of individual cannabinoids and identified ten with anticonvulsant properties.”
“We are now interested in investigating what happens when we combine these anticonvulsant properties. It remains an open possibility that greater anticonvulsant effects are achieved when the cannabinoids are administered in combination.”
Introducing our new B2B title
- BPNA publishes new guidance on prescribing medical cannabis in epilepsy
- 71% of CBD users self-determine dosage without professional help
- Menopause: Could CBD offer relief from symptoms?
- “The system needs to change” – Father desperate to access medical cannabis for his disabled son
- “Millions of cannabis patients face criminalisation behind the wheel – even if completely unimpaired”
- CBD guides: Can CBD help with depression?
News11 months ago
Community extends support to cannabis icon Rick Simpson
News1 year ago
NHS lines up cannabis medicine manufacturing
Case Studies2 years ago
CBD oil and fibromyalgia – a case study
News1 year ago
Cancer survivor claims cannabis oil helped her beat brain tumour
Insight1 year ago
I’ve gone from a wheelchair to walking thanks to cannabis
News10 months ago
UK grants second licence to grow high-THC medical cannabis
Feature1 year ago
Medical cannabis could help long-term effects of COVID-19, says David Nutt
News11 months ago
Living with chronic fatigue – my CBD story